DocGo (NASDAQ:DCGO) Cut to Neutral at BTIG Research

BTIG Research lowered shares of DocGo (NASDAQ:DCGOFree Report) from a buy rating to a neutral rating in a research report report published on Friday, MarketBeat.com reports.

A number of other brokerages have also recently commented on DCGO. Needham & Company LLC reaffirmed a “buy” rating and set a $4.00 price target on shares of DocGo in a research report on Tuesday, April 8th. Stifel Nicolaus cut their target price on DocGo from $6.50 to $5.50 and set a “buy” rating on the stock in a research report on Friday, February 28th. Finally, Deutsche Bank Aktiengesellschaft downgraded DocGo from a “buy” rating to a “hold” rating and lowered their target price for the stock from $5.00 to $2.85 in a report on Friday, February 28th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $4.09.

Check Out Our Latest Report on DCGO

DocGo Trading Down 39.5 %

Shares of DCGO stock opened at $1.41 on Friday. DocGo has a 1-year low of $1.39 and a 1-year high of $5.68. The stock has a market cap of $143.80 million, a price-to-earnings ratio of 5.04, a PEG ratio of 14.16 and a beta of 1.14. The stock has a 50-day moving average of $2.52 and a 200-day moving average of $3.68.

DocGo (NASDAQ:DCGOGet Free Report) last released its earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.08). DocGo had a net margin of 4.35% and a return on equity of 8.90%. Sell-side analysts forecast that DocGo will post 0.25 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Jefferies Financial Group Inc. grew its stake in DocGo by 6,874.1% in the first quarter. Jefferies Financial Group Inc. now owns 2,029,456 shares of the company’s stock valued at $5,358,000 after acquiring an additional 2,000,356 shares during the period. Victory Capital Management Inc. grew its position in DocGo by 546.1% in the 1st quarter. Victory Capital Management Inc. now owns 372,487 shares of the company’s stock valued at $983,000 after purchasing an additional 314,838 shares during the period. Isthmus Partners LLC increased its stake in DocGo by 2.3% during the 1st quarter. Isthmus Partners LLC now owns 638,400 shares of the company’s stock valued at $1,685,000 after purchasing an additional 14,472 shares in the last quarter. Diversify Wealth Management LLC bought a new stake in DocGo during the 1st quarter valued at $223,000. Finally, Bank of New York Mellon Corp lifted its stake in shares of DocGo by 8.1% in the first quarter. Bank of New York Mellon Corp now owns 365,468 shares of the company’s stock valued at $965,000 after buying an additional 27,309 shares in the last quarter. 56.44% of the stock is owned by institutional investors and hedge funds.

About DocGo

(Get Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Further Reading

Analyst Recommendations for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.